2006

May

• Polycythemia Vera -

• Chronic Myelogenous Leukemia -

• Myeloproliferative Disorders -

• Acute Leukemias -

• Myelodysplasia -

• Low-grade prostate cancer may not require aggressive treatment -

• Home urine testing cuts bladder cancer deaths -

• Uncommon Ovarian Tumors -

• Granulosa-Stromal Cell Tumors -

• Sex Cord-Stromal Tumors -

• Mixed Germ-Cell Tumors -

• Choriocarcinoma of the Ovary -

• Embryonal Carcinoma -

• Endodermal Sinus Tumors -

• Immature Teratomas -

• Dysgerminomas -

• Nonepithelial Ovarian Cancer Diagnosis -

• Germ Cell Malignancies -

• Epithelial Ovarian Cancer -

• Ovarian Cancer Etiology and Epidemiology -

• Nonepithelial Ovarian Cancer -

• Ovarian Cancer Prevention -

• Survival of Patients with Advanced Ovarian Cancer -

• Palliative Radiotherapy in Ovarian Cancer -

• Immunotherapy in Ovarian Cancer -

• Consolidation Bhemotherapy and Immuno-therapy in Ovarian Cancer -

• Follow-up Examinations in Ovarian Cancer -

• Assessment of Response in Patients who are Clinically free of Disease -

• Management of Advanced Invasive Ovarian Cancer -

• Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer -

• Chemotherapy for Advanced Stage Epithelial Ovarian Cancer -

• Treatment of Advanced Stage Epithelial Ovarian Cancer -

• Treatment of Early stage Ovarian Cancer -

• Staging of Ovarian Cancer -

• Ovarian Cancer Screening -

• Ovarian Cancer Diagnosis -

• Ovarian Cancer Clinical Features -

• Ovarian Cancer - Patterns of Spread -

• Ovarian Cancer Classification and Pathology -

• Biology and Prognosis of Ovarian Neoplasms -

• Ovarian Cancer Embryology -

• Genetic Risk for Epithelial Ovarian Cancer -

• MRI cost-effective for some women at high-risk of breast cancer -

• Heavy marijuana use not linked to lung cancer -

• Gestational Trophoblastic Disease -

• Fallopian Tube Cancer -

• Vaginal Cancer -

• Vulvar Cancer -

• Cervical Cancer -

• Ovarian Cancer -

<< Back to main